Posttranslational regulation of Myc function in response to phorbol ester/interferon-γ-induced differentiation of v-Myc-transformed U-937 monoblasts

被引:25
作者
Bahram, F
Wu, SQ
Öberg, F
Lüscher, B
Larsson, LG
机构
[1] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden
[2] Med Hsch Hannover, Inst Mol Biol, Hannover, Germany
关键词
D O I
10.1182/blood.V93.11.3900.411a42_3900_3912
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The transcription factors of the Myc/Max/Mad network are important regulators of cell growth, differentiation, and apoptosis and are frequently involved in tumor development. Constitutive expression of v-Myc blocks phorbol ester (TPA)-induced differentiation of human U-937 monoblasts. However, costimulation with interferon-gamma (IFN-gamma) and TPA restores terminal differentiation and G(1) cell-cycle arrest despite continuous expression of v-Myc. The mechanism by which TPA + IFN-gamma counteract v-Myc activity has not been unravelled. Our results show that TPA + IFN-gamma, treatment led to an inhibition of v-Myc- and c-Myc-dependent transcription, and a specific reduction of v-Myc:Max complexes and associated DNA-binding activity whereas the steady state level of the v-Myc protein was only marginally affected. In contrast, TPA + IFN-gamma costimulation neither increased the expression of Mad1 or other mad/mnt family genes nor altered heterodimerization or DNA-binding activity of Mad1, The reduced amount of v-Myc:Max heterodimers in response to treatment was accompanied by partial dephosphorylation of v-Myc and c-Myc. Phosphatase treatment of Myc:Max complexes lead to their dissociation, thus mimicking the effect of TPA + IFN-gamma, In addition to modulation of the expression of Myc/Max/Mad network proteins, posttranslational negative regulation of Myc by external signals may, therefore, be an alternative biologically important level of control with potential therapeutic relevance for hematopoietic and other tumors with deregulated Myc expression. (C) 1999 by The American Society of Hematology.
引用
收藏
页码:3900 / 3912
页数:13
相关论文
共 62 条
  • [1] ALVAREZ E, 1991, J BIOL CHEM, V266, P15277
  • [2] ONCOGENIC ACTIVITY OF THE C-MYC PROTEIN REQUIRES DIMERIZATION WITH MAX
    AMATI, B
    BROOKS, MW
    LEVY, N
    LITTLEWOOD, TD
    EVAN, GI
    LAND, H
    [J]. CELL, 1993, 72 (02) : 233 - 245
  • [3] TRANSCRIPTIONAL ACTIVATION BY THE HUMAN C-MYC ONCOPROTEIN IN YEAST REQUIRES INTERACTION WITH MAX
    AMATI, B
    DALTON, S
    BROOKS, MW
    LITTLEWOOD, TD
    EVAN, GI
    LAND, H
    [J]. NATURE, 1992, 359 (6394) : 423 - 426
  • [4] SEQUENCE-SPECIFIC TRANSCRIPTIONAL ACTIVATION BY MYC AND REPRESSION BY MAX
    AMIN, C
    WAGNER, AJ
    HAY, N
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (01) : 383 - 390
  • [5] MAD - A HETERODIMERIC PARTNER FOR MAX THAT ANTAGONIZES MYC TRANSCRIPTIONAL ACTIVITY
    AYER, DE
    KRETZNER, L
    EISENMAN, RN
    [J]. CELL, 1993, 72 (02) : 211 - 222
  • [6] A SWITCH FROM MYC-MAX TO MAD-MAX HETEROCOMPLEXES ACCOMPANIES MONOCYTE/MACROPHAGE DIFFERENTIATION
    AYER, DE
    EISENMAN, RN
    [J]. GENES & DEVELOPMENT, 1993, 7 (11) : 2110 - 2119
  • [7] CASEIN KINASE-II INHIBITS THE DNA-BINDING ACTIVITY OF MAX HOMODIMERS BUT NOT MYC MAX HETERODIMERS
    BERBERICH, SJ
    COLE, MD
    [J]. GENES & DEVELOPMENT, 1992, 6 (02) : 166 - 176
  • [8] SEQUENCE-SPECIFIC DNA-BINDING BY THE C-MYC PROTEIN
    BLACKWELL, TK
    KRETZNER, L
    BLACKWOOD, EM
    EISENMAN, RN
    WEINTRAUB, H
    [J]. SCIENCE, 1990, 250 (4984) : 1149 - 1151
  • [9] MYC AND MAX ASSOCIATE INVIVO
    BLACKWOOD, EM
    LUSCHER, B
    EISENMAN, RN
    [J]. GENES & DEVELOPMENT, 1992, 6 (01) : 71 - 80
  • [10] MAX - A HELIX-LOOP-HELIX ZIPPER PROTEIN THAT FORMS A SEQUENCE-SPECIFIC DNA-BINDING COMPLEX WITH MYC
    BLACKWOOD, EM
    EISENMAN, RN
    [J]. SCIENCE, 1991, 251 (4998) : 1211 - 1217